IHE has considerable experience in cutting edge research on the economics of obesity and diabetes, including more than 50 peer-reviewed publications.
IHE works with health authorities, life science companies, and academia on projects ranging from developing national treatment guidelines to estimating future disease burden and from early stage decision-making to market access.
- Have developed two internationally established and validated economic models of Type 2 diabetes, which have been accepted by HTA authorities in Sweden, Norway, U.K., Canada, Scotland, Ireland, and Australia
- Have developed an economic micro-simulation model of Type 1 diabetes, which has been used for the Swedish Dental and Pharmaceutical Benefits Agency (TLV) for decision-making, among others
- Have collaborated successfully with life science companies to obtain market access in European and North American countries
- Have been commissioned by the National Board of Health and Welfare in Sweden to assist with development of diabetes treatment guidelines
- Supervise doctoral students at Lund University and Karolinska Institute, perform peer review, and participate in diabetes-related advisory boards as health economics experts
- Serve on the executive committee of biennial Mt. Hood Diabetes Modelling Challenge Network
Special areas of competence include
- Economic modelling and market access support
- Model development
- Analysis of registry data and real-world evidence
- Literature review
- Patient preferences and Willingness-to-Pay
For more information, please contact: email@example.com